Moderna To Develop mRNA Vaccines in China
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.
The US and China may be taking jabs at one another over trade and other stuff, but that isn't stopping Beijing from inviting an American company to produce a new jab for the nation of 1.4 billion.
Moderna announced Wednesday it's struck a deal with Chinese officials to let it develop messenger RNA (mRNA) drugs in the country. It's a win that could pave the way for more Western vaccine producers looking to break into China.
Source Fool.com
Moderna Inc. Stock
€50.25
5.760%
Based on 9 Buy predictions and 8 Sell predictions the sentiment towards Moderna Inc. is rather balanced.
On the other hand, the target price of 21 € is below the current price of 50.25 € for Moderna Inc., so the potential is actually -58.21%.
